Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory
Tóm tắt
Extensive clinical and genetic heterogeneity of inherited cancers has allowed multi-gene panel testing to become an efficient means for identification of patients with an inherited predisposition to a broad spectrum of syndromic and nonsyndromic forms of cancer. This study reports our experience with a 27-gene inherited cancer panel on a cohort of 630 consecutive individuals referred for testing at our laboratory with the following objectives: 1. Determine the rates for positive cases and those with variants of uncertain clinical significance (VUS) relative to data published in the recent literature, 2. Examine heterogeneity among the constituent genes on the panel, and 3. Review test uptake in the cohort relative to other reports describing outcomes for expanded panel testing. Clinical and genomic data were reviewed on 630 individuals tested on a panel of 27 genes selected on the basis of high (≥ 40%) or moderate to low (≤ 40%) lifetime risk of hereditary cancer. These patients were not enriched for adherence to the National Comprehensive Cancer Network (NCCN) criteria for Hereditary Breast and Ovarian Cancer (HBOC) or Lynch Syndrome (LS) and constitute a referral laboratory cohort. Sixty-five individuals with variants classified as pathogenic or likely pathogenic across 14 genes were identified for an overall positive rate of 10.3%. Although a family history of cancer constituted a major reason for referral, accounting for 84% of our cohort, excluding patients with a known familial variant did not have a significant impact on the observed positive rate (9% vs 10.3%). More than half (58%) of the pathogenic or likely pathogenic variants were observed in high or moderate to low risk genes on the panel, while only 42% occurred in classic HBOC or LS-associated genes. These results provide the actual percentage of family or personal history of cancer that can be attributed to pathogenic or likely pathogenic variants in one or more of the genes on our panel and corroborate the utility of multi-gene panels over sequential testing to identify individuals with an inherited predisposition to cancer.
Tài liệu tham khảo
citation_journal_title=Nat Genet; citation_title=The emerging landscape of breast cancer susceptibility; citation_author=MR Stratton, N Rahman; citation_volume=40; citation_publication_date=2008; citation_pages=17-22; citation_doi=10.1038/ng.2007.53; citation_id=CR1
citation_journal_title=Gastroenterology; citation_title=Identification of a variety of mutations in cancer predisposition genes in patients with suspected lynch syndrome; citation_author=MB Yurgelun, B Allen, RR Kaldate, KR Bowles, T Judkins, P Kaushik; citation_volume=149; citation_publication_date=2015; citation_pages=604-613; citation_doi=10.1053/j.gastro.2015.05.006; citation_id=CR2
Petrucelli N, Daly MB, Pal T. Gene reviews (R): eds R. A. Pagon et al.; 1993.
citation_journal_title=Genet Med; citation_title=ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis); citation_author=M Hegde, M Ferber, R Mao, W Samowitz, A Ganguly; citation_volume=16; citation_publication_date=2014; citation_pages=101-116; citation_doi=10.1038/gim.2013.166; citation_id=CR4
Kohlmann W, Gruber SB. Gene reviews (R): eds R. A. Pagon et al.; 1993.
citation_journal_title=Biomed Res Int; citation_title=Hereditary breast cancer: the era of new susceptibility genes; citation_author=P Apostolou, F Fostira; citation_volume=2013; citation_publication_date=2013; citation_pages=747318; citation_doi=10.1155/2013/747318; citation_id=CR6
citation_journal_title=J Mol Diagn; citation_title=A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients; citation_author=SE Lincoln, Y Kobayashi, MJ Anderson, S Yang, AJ Desmond, MA Mills; citation_volume=17; citation_publication_date=2015; citation_pages=533-544; citation_doi=10.1016/j.jmoldx.2015.04.009; citation_id=CR7
citation_journal_title=J Clin Oncol; citation_title=Cancer susceptibility gene mutations in individuals with colorectal cancer; citation_author=MB Yurgelun, MH Kulke, CS Fuchs, BA Allen, H Uno, JL Hornick; citation_volume=35; citation_publication_date=2017; citation_pages=1086-1095; citation_doi=10.1200/JCO.2016.71.0012; citation_id=CR8
citation_journal_title=Mod Pathol; citation_title=Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort; citation_author=KL Ring, AS Bruegl, BA Allen, EP Elkin, N Singh, AR Hartman; citation_volume=29; citation_publication_date=2016; citation_pages=1381-1389; citation_doi=10.1038/modpathol.2016.135; citation_id=CR9
citation_journal_title=Gynecol Oncol; citation_title=Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2; citation_author=LE Minion, JS Dolinsky, DM Chase, CL Dunlop, EC Chao, BJ Monk; citation_volume=137; citation_publication_date=2015; citation_pages=86-92; citation_doi=10.1016/j.ygyno.2015.01.537; citation_id=CR10
citation_journal_title=Cancer; citation_title=Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel; citation_author=N Tung, C Battelli, B Allen, R Kaldate, S Bhatnagar, K Bowles; citation_volume=121; citation_publication_date=2015; citation_pages=25-33; citation_doi=10.1002/cncr.29010; citation_id=CR11
citation_journal_title=Genet Med.; citation_title=Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients; citation_author=H LaDuca, AJ Stuenkel, JS Dolinsky, S Keiles, S Tandy, T Pesaran; citation_volume=16; citation_publication_date=2014; citation_pages=830-837; citation_doi=10.1038/gim.2014.40; citation_id=CR12
citation_journal_title=J Hum Genet; citation_title=Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India; citation_author=AU Mannan, J Singh, R Lakshmikeshava, N Thota, S Singh, TS Sowmya; citation_volume=61; citation_publication_date=2016; citation_pages=515-522; citation_doi=10.1038/jhg.2016.4; citation_id=CR13
citation_journal_title=Genet Med.; citation_title=Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing; citation_author=LR Susswein, ML Marshall, R Nusbaum, KJ Vogel Postula, SM Weissman, L Yackowski; citation_volume=18; citation_publication_date=2016; citation_pages=823-832; citation_doi=10.1038/gim.2015.166; citation_id=CR14
citation_journal_title=Am J Hum Genet; citation_title=Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome; citation_author=M De Vos, BE Hayward, S Picton, E Sheridan, DT Bonthron; citation_volume=74; citation_publication_date=2004; citation_pages=954-964; citation_doi=10.1086/420796; citation_id=CR15
citation_journal_title=Arch Pathol Lab Med; citation_title=College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests; citation_author=N Aziz, Q Zhao, L Bry, DK Driscoll, B Funke, JS Gibson; citation_volume=139; citation_publication_date=2015; citation_pages=481-493; citation_doi=10.5858/arpa.2014-0250-CP; citation_id=CR16
citation_journal_title=Genet Med.; citation_title=Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology; citation_author=S Richards, N Aziz, S Bale, D Bick, S Das, J Gastier-Foster; citation_volume=17; citation_publication_date=2015; citation_pages=405-424; citation_doi=10.1038/gim.2015.30; citation_id=CR17
Exome Aggregation Consortium (ExAC). Cambridge. 2015.
http://exac.broadinstitute.org
. Accessed March 2017.
Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP). Seattle.
http://evs.gs.washington.edu/EVS/
. Accessed March 2017.
citation_journal_title=Nature; citation_title=An integrated map of genetic variation from 1,092 human genomes; citation_author=C Genomes Project, GR Abecasis, A Auton, LD Brooks, MA DePristo, RM Durbin; citation_volume=491; citation_publication_date=2012; citation_pages=56-65; citation_doi=10.1038/nature11632; citation_id=CR20
citation_journal_title=Hum Mutat; citation_title=BRCA share: a collection of clinical BRCA gene variants; citation_author=C Beroud, SI Letovsky, CD Braastad, SM Caputo, O Beaudoux, YJ Bignon; citation_volume=37; citation_publication_date=2016; citation_pages=1318-1328; citation_doi=10.1002/humu.23113; citation_id=CR21
citation_journal_title=Familial Cancer; citation_title=The InSiGHT database: utilizing 100 years of insights into lynch syndrome; citation_author=JP Plazzer, RH Sijmons, MO Woods, P Peltomaki, B Thompson, JT Den Dunnen; citation_volume=12; citation_publication_date=2013; citation_pages=175-180; citation_doi=10.1007/s10689-013-9616-0; citation_id=CR22
citation_journal_title=Gastroenterology; citation_title=Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer; citation_author=AK Win, JG Dowty, SP Cleary, H Kim, DD Buchanan, JP Young; citation_volume=146; citation_publication_date=2014; citation_pages=1208-1211; citation_doi=10.1053/j.gastro.2014.01.022; citation_id=CR23
citation_journal_title=Carcinogenesis; citation_title=IEncreased frequency of disease-causing MYH mutations in colon cancer families; citation_author=P Peterlongo, N Mitra, A Sanchez de Abajo, M de la Hoya, C Bassi, L Bertario; citation_volume=27; citation_publication_date=2006; citation_pages=2243-2249; citation_doi=10.1093/carcin/bgl093; citation_id=CR24
citation_journal_title=Cancer Epidemiol Biomark Prev; citation_title=Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study; citation_author=MA Jenkins, ME Croitoru, N Monga, SP Cleary, M Cotterchio, JL Hopper; citation_volume=15; citation_publication_date=2006; citation_pages=312-314; citation_doi=10.1158/1055-9965.EPI-05-0793; citation_id=CR25
citation_journal_title=J Clin Oncol; citation_title=Clinical implications of the colorectal cancer risk associated with MUTYH mutation; citation_author=SJ Lubbe, MC Di Bernardo, IP Chandler, RS Houlston; citation_volume=27; citation_publication_date=2009; citation_pages=3975-3980; citation_doi=10.1200/JCO.2008.21.6853; citation_id=CR26
NCCN Clinical practice guidelines in oncology: genetic/familial high-risk assessment: Colorectal. Version 2. 2017.
http://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf
. Accessed May 2017.
citation_journal_title=Genet Med; citation_title=Improving performance of multigene panels for genomic analysis of cancer predisposition; citation_author=BH Shirts, S Casadei, AL Jacobson, MK Lee, S Gulsuner, RL Bennett; citation_volume=18; citation_publication_date=2016; citation_pages=974-981; citation_doi=10.1038/gim.2015.212; citation_id=CR28
citation_journal_title=Nat Genet; citation_title=Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles; citation_author=S Seal, D Thompson, A Renwick, A Elliott, P Kelly, R Barfoot; citation_volume=38; citation_publication_date=2006; citation_pages=1239-1241; citation_doi=10.1038/ng1902; citation_id=CR29
citation_journal_title=J Clin Oncol; citation_title=Clinical genetics testing laboratories have a remarkably low rate of clinically significant discordance when interpreting variants in hereditary cancer syndrome genes; citation_author=RL Nussbaum, S Yang, SE Lincoln; citation_volume=35; citation_publication_date=2017; citation_pages=1259-1261; citation_doi=10.1200/JCO.2016.70.9451; citation_id=CR30
citation_journal_title=J Med Genet; citation_title=Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘care for CMMRD’ (C4CMMRD); citation_author=K Wimmer, CP Kratz, HF Vasen, O Caron, C Colas, N Entz-Werle; citation_volume=51; citation_publication_date=2014; citation_pages=355-365; citation_doi=10.1136/jmedgenet-2014-102284; citation_id=CR31
citation_journal_title=Gastroenterology; citation_title=The clinical phenotype of lynch syndrome due to germ-line PMS2 mutations; citation_author=L Senter, M Clendenning, K Sotamaa, H Hampel, J Green, JD Potter; citation_volume=135; citation_publication_date=2008; citation_pages=419-428; citation_doi=10.1053/j.gastro.2008.04.026; citation_id=CR32